Key result
Fetuses with congenital heart disease exhibited significantly reduced cortical gray matter, subcortical brain tissue, cerebellum, and brainstem volumes compared to healthy fetuses (all P<0.05).
Why the study?
Although brain development alterations occur in third-trimester fetuses with congenital heart disease, little is known about the timing and pattern of these alterations in earlier stages of pregnancy.
Does 3D volumetric MRI detect early alterations in brain growth in fetuses with congenital heart disease compared to healthy fetuses?
Observational (n=160)
Does 3D volumetric MRI detect early alterations in brain growth in fetuses with congenital heart disease compared to healthy fetuses?
3D volumetric MRI can detect early alterations in brain development trajectories, including reduced gray matter and brainstem volumes, in fetuses with congenital heart disease before 26 weeks of gestation.
Answers are grounded in this paper and cite their sources.
Detects early brain volume reductions in CHD fetuses; hypothesis-generating for prenatal risk stratification, requires prospective validation.
BACKGROUND: Several published studies have shown alterations of brain development in third-trimester fetuses with congenital heart disease (CHD). However, little is known about the timing and pattern of altered brain development in fetuses with CHD. PURPOSE: To investigate the changes in the volume of intracranial structures in fetuses with CHD by three-dimensional (3D) volumetric magnetic resonance imaging (MRI) in the earlier stages of pregnancy (median gestational age [GA], 26 weeks). STUDY TYPE: Retrospective. POPULATION: Forty women carrying a fetus with CHD (including 20 fetuses with GA <26 weeks) and 120 pregnant women carrying a healthy fetus (including 50 fetuses with GA <26 weeks). FIELD STRENGTH/SEQUENCE: Two-dimensional single-shot turbo spin echo sequence at 1.5 -T. ASSESSMENT: Three-dimensional volumetric parameters from slice-to-volume registered images, including cortical gray matter volume (GMV), subcortical brain tissue volume (SBV), intracranial cavity volume (ICV), lateral ventricles volume (VV), cerebellum, brainstem, and extra-cerebrospinal fluid (e-CSF) were quantified by manual segmentation from one primary and two secondary observers. STATISTICAL TESTS: Volumes were presented graphically with quadratic curve fitting. Scatterplots were produced mapping volumes against GA in normal and CHD fetuses. For GA <26 weeks, Z scores were calculated and Student's t-tests were conducted to compare volumes between the normal and CHD fetuses. RESULTS: In fetuses with CHD GMV, SBV, cerebellum, and brainstem were significantly reduced (all P < 0.05) in early stages of pregnancy (GA <26 weeks), with differences becoming progressively greater with increasing GA. Compared with normal fetuses, e-CSF, e-CSF to ICV ratio, and VV were higher in fetuses with CHD (all P < 0.05). However, ICV volume and the GMV to SBV ratio were not significantly reduced in the CHD group (P = 0.94 and P = 0.13, respectively) during the middle gestation (GA <26 weeks). DATA CONCLUSION: There appear to be alterations of brain development trajectory in CHD fetuses that can be detected by 3D volumetric MRI in the earlier stages of pregnancy. LEVEL OF EVIDENCE: 4 TECHNICAL EFFICACY: Stage 3.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2021) conducted an observational in Congenital heart disease in fetuses (n=160). Fetal congenital heart disease vs. Healthy fetus was evaluated on Volume of intracranial structures including cortical gray matter, subcortical brain tissue, cerebellum, and brainstem (p=<0.05). Fetuses with congenital heart disease exhibited significantly reduced cortical gray matter, subcortical brain tissue, cerebellum, and brainstem volumes compared to healthy fetuses (all P<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: